{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:07:08Z","timestamp":1791994028747,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"crossref","award":["MYRG2015-00230-FHS"],"award-info":[{"award-number":["MYRG2015-00230-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004733","name":"University of Macau","doi-asserted-by":"crossref","award":["MYRG2016-00005-FHS"],"award-info":[{"award-number":["MYRG2016-00005-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research & Development Program of China","award":["2016YFC1307200"],"award-info":[{"award-number":["2016YFC1307200"]}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"crossref","award":["ZYLX201607"],"award-info":[{"award-number":["ZYLX201607"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals\u2019 Ascent Plan","doi-asserted-by":"crossref","award":["DFL20151801"],"award-info":[{"award-number":["DFL20151801"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jpsychires.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T12:21:55Z","timestamp":1533212515000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-2031","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor S.","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-0029","authenticated-orcid":false,"given":"Yu-Tao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.08.002_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00429","article-title":"Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: a comparative meta-analysis","volume":"3","author":"Ahmed","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib2","series-title":"Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib3","series-title":"Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11632020-000000000-00000","article-title":"Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?","volume":"26","author":"Attard","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib8","first-page":"117","article-title":"Neuroleptic-resistant schizophrenia treated with clozapine and ECT","volume":"12","author":"Benatov","year":"1996","journal-title":"Convuls Ther."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00124509-199812000-00012","article-title":"Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia","volume":"14","author":"Bhatia","year":"1998","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/YCT.0b013e31821a8f05","article-title":"Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes","volume":"27","author":"Biedermann","year":"2011","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib11","first-page":"1423","article-title":"A comparison study of MECT combining clozapine in the treatment of treatment-resistant schizophrenia (In Chinese)","volume":"20","author":"Cai","year":"2008","journal-title":"Med. J. Chin. People's Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib12","first-page":"57","article-title":"The control study of modified electroconvulsive therapy in treatment-refractory schizophrenia (In Chinese)","volume":"42","author":"Chen","year":"2012","journal-title":"Xinjiang Med. J."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib13","series-title":"Electroconvulsive Therapy (In Chinese)","author":"Chen","year":"2009"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2017.0624","article-title":"Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence","volume":"74","author":"Correll","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3056","key":"10.1016\/j.jpsychires.2018.08.002_bib15","first-page":"115","article-title":"Efficacy and safety of clozapine combined electroconvulsive therapy in the treatment of refractory schizophrenia (In Chinese)","volume":"23","author":"Du","year":"2011","journal-title":"Med. J. Chin. People's Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib17","first-page":"263","article-title":"Treatment-resistant schizophrenia","volume":"14","author":"Ferentinos","year":"2003","journal-title":"Psychiatriki"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/YCT.0b013e3181f816f6","article-title":"Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia: a case report and systematic literature review","volume":"27","author":"Gerretsen","year":"2011","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002826-200601000-00012","article-title":"Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia","volume":"29","author":"Havaki-Kontaxaki","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib20","series-title":"Cochrane handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib22","first-page":"190","article-title":"Clozapine does not increase ECT-seizure duration. Canadian Journal of Psychiatry","volume":"44","author":"Husni","year":"1999","journal-title":"Rev. Canad. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0278-5846(99)00015-9","article-title":"Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia","volume":"23","author":"Kales","year":"1999","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamapsychiatry.2015.2966","article-title":"The role of clozapine in treatment-resistant schizophrenia","volume":"73","author":"Kane","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative Syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00406-004-0517-y","article-title":"Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study","volume":"254","author":"Kho","year":"2004","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib29","doi-asserted-by":"crossref","DOI":"10.5867\/medwave.2016.6577","article-title":"Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?","volume":"16","author":"Kittsteiner Manubens","year":"2016","journal-title":"Medwave"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002826-200001000-00003","article-title":"Combined electroconvulsive-clozapine therapy","volume":"23","author":"Kupchik","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0019-5545.43067","article-title":"Combination of ECT and clozapine in drug-resistant schizophrenia","volume":"47","author":"Kurian","year":"2005","journal-title":"Indian J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2016.01.024","article-title":"Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis","volume":"171","author":"Lally","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib35","first-page":"199","article-title":"The clinical analysis of clozapine combined MECT in the treatment of refractory schizophrenia (In Chinese)","volume":"7","author":"Liu","year":"2013","journal-title":"Yiayao Qianyan"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0366-6999.147815","article-title":"Efficacy and safety of electroconvulsive therapy in the treatment of refractory schizophrenia (In Chinese)","volume":"13","author":"Liu","year":"2015","journal-title":"Guide. China Med."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib37","first-page":"233","article-title":"Efficacy of clozapine combined MECT in the treatment of refractory schizophrenia (In Chinese)","author":"Lou","year":"2013","journal-title":"China J. Pharmaceut. Econ."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.158.1.135b","article-title":"ECT following clozapine","volume":"158","author":"Masiar","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3923\/pjbs.2007.4287.4290","article-title":"Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients","volume":"10","author":"Masoudzadeh","year":"2007","journal-title":"Pakistan J. Biol. Sci."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/S000712500029692X","article-title":"Dimensions of outcome with clozapine","author":"Meltzer","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/BF00442563","article-title":"A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.152.2.183","article-title":"Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment","volume":"152","author":"Meltzer","year":"1995","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/YCO.0000000000000159","article-title":"Schizophrenia: when clozapine fails","volume":"28","author":"Miyamoto","year":"2015","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/geronj\/39.2.187","article-title":"The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit","volume":"39","author":"Overall","year":"1984","journal-title":"J. Gerontol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euroneuro.2011.08.005","article-title":"Clozapine resistance: augmentation strategies","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib50","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14740338.2016.1191468","article-title":"Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use","volume":"15","author":"Remington","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib51","first-page":"141","article-title":"Combining clozapine with ECT","volume":"8","author":"Safferman","year":"1992","journal-title":"Convuls Ther."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatr.. Rev. Canad. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib55","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/schbul\/sbr004","article-title":"Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib56","article-title":"Comparative effectiveness of antipsychotic drugs for rehospitalization in schizophrenia-a nationwide study with 20-year follow-up","author":"Taipale","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.2011.01792.x","article-title":"Augmentation of clozapine with a second antipsychotic - a meta-analysis","volume":"125","author":"Taylor","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib58","first-page":"CD000076","article-title":"Electroconvulsive therapy for schizophrenia","author":"Tharyan","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-World effectiveness of antipsychotic treatments in a nationwide cohort of 29823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib62","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.08.002_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0034-1385930","article-title":"Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis","volume":"47","author":"Veerman","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib64","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s40265-017-0789-y","article-title":"Treatment for negative symptoms in schizophrenia: a comprehensive review","volume":"77","author":"Veerman","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sby015.215","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years","author":"Vermeulen","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib66","first-page":"503","article-title":"Efficacy of different course of modified electro-convulsive therapy on treatment-refracted schizophrenia (In Chinese)","volume":"9","author":"Wan","year":"2009","journal-title":"J. Neurosci. Ment. Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib67","first-page":"206","article-title":"Efficacy and safety of treating patients with refractory schizophrenia with antipsychotic medication and adjunctive electroconvulsive therapy: a systematic review and meta-analysis","volume":"27","author":"Wang","year":"2015","journal-title":"Shanghai Arch Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib68","first-page":"252","article-title":"Modified electroconvulsive therapy in the treatment of refractory schizophrenia (In Chinese)","volume":"21","author":"Wang","year":"2011","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib69","series-title":"The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: a Task Force Report of the American Psychiatric Association","author":"Weiner","year":"2008"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib70","first-page":"113","article-title":"Clinical observation on MECT combined with clozapine for refractory schizophrenia (In Chinese)","volume":"7","author":"Xia","year":"2016","journal-title":"China Health Stand. Manag."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.08.002_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/appy.12277","article-title":"Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009)","volume":"9","author":"Xiang","year":"2017","journal-title":"Asia Pac. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib72","first-page":"348","article-title":"Clinical observation of MECT combined with clozapine for refractory schizophrenia (In Chinese)","volume":"28","author":"Xiong","year":"2015","journal-title":"Sichuan Ment. Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib73","first-page":"485","article-title":"A comparative study of MECT combined with excitement aggressive behavior treatment on refractory schizophrenia (In Chinese)","volume":"17","author":"Yang","year":"2005","journal-title":"Med. J. Chin. People's Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib74","first-page":"89","article-title":"Modified electroconvulsive therapy in the treatment of refractory schizophrenia with negative symptoms (In Chinese)","volume":"53","author":"Yu","year":"2015","journal-title":"China Modern Doctor"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib75","first-page":"95","article-title":"Comparative study of clozapine versus clozapine combined with MECT in the treatment of refractory schizophrenia (In Chinese)","volume":"22","author":"Zeng","year":"2010","journal-title":"Shanghai Arch. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib76","series-title":"The Efficacy and Safety of MECT for Treatment-resistant Schizophrenia (In Chinese)","first-page":"67","author":"Zhang","year":"2017"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib77","first-page":"440","article-title":"Effects of modified electroconvulsive therapy combined with clozapine in patients with treatment-refractory schizophrenia (In Chinese)","volume":"24","author":"Zhang","year":"2010","journal-title":"Chin. Ment. Health J."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib78","first-page":"124","article-title":"A comparative study of clozapine combined electroconvulsive therapy in the treatment of refractory schizophrenia (In Chinese)","volume":"24","author":"Zhang","year":"2011","journal-title":"J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.08.002_bib79","first-page":"2859","article-title":"A comparative study of clozapine versus clozapine combined with MECT in the treatment of refractory schizophrenia (In Chinese)","volume":"24","author":"Zhao","year":"2012","journal-title":"Med. J. Chin. People's Health"},{"key":"10.1016\/j.jpsychires.2018.08.002_bib80","article-title":"Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: meta-analysis of randomized controlled trials","volume":"11","author":"Zheng","year":"2017","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1016\/j.jpsychires.2026.04.037","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618303765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618303765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:11:04Z","timestamp":1758366664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618303765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":80,"alternative-id":["S0022395618303765"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.08.002","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}